引用次数
引用: 1,258
H-指数: 18
I10-指数 : 32
出版物: 111
Impact of HCV treatment in patients with advanced hepatocellular carcinoma on sorafenib.
Michael Herman , Yuhua Zhang , Lisa Wang , Hao-Wen Sim
Journal of Clinical Oncology 37
2019
Impact of adjuvant therapy in patients with a microscopically positive margin after resection for gastric and esophageal cancers
Lucy X. Ma , Osvaldo Espin-Garcia , Charles H. Lim , Di M. Jiang
Journal of gastrointestinal oncology 11 ( 2) 356 -365
1
2020
The impact of lung and bone metastases on prognosis in advanced PDAC.
Grainne M. O'Kane , Adriana Fraser , Stephanie Moignard , Anna Dodd
Journal of Clinical Oncology 36 494 -494
2018
Outcomes for advanced HER2-positive gastroesophageal cancer by anatomical location: Experience from the Princess Margaret Cancer Centre.
Charles Henry Lim , Daniel Yokom , Di Maria Jiang , Lucy Xiaolu Ma
Journal of Clinical Oncology 36 ( 4) 131 -131
2018
Survival outcomes for de novo versus relapsed stage IV gastric and gastroesophageal junction (GEJ) adenocarcinoma
Bryan Anthony Chan , Hao-Wen Sim , Akina Natori , Stephanie Moignard
Journal of Clinical Oncology 36 ( 4) 148 -148
2018
Relationship between human epidermal growth factor receptor 2 (HER2) status and central nervous system metastases in gastroesophageal cancer.
Lucy Xiaolu Ma , Charles Henry Lim , Peiran Sun , Maria Jiang
Journal of Clinical Oncology 36 ( 4) 145 -145
2018
Patterns of recurrence and outcomes after curative resection of locally advanced HER2-positive gastroesophageal cancer (HPGEC)
Di Maria Jiang , Charles Henry Lim , Lucy Xiaolu Ma , Peiran Sun
Journal of Clinical Oncology 36 ( 4) 147 -147
2018
Management of metastatic gastric and esophageal cancer in older adults
Gail Elizabeth Darling , Carol Jane Swallow , James D. Brierley , Rebecca Wong
Journal of Clinical Oncology 36 ( 4) 163 -163
2018
CBMT-06. LOWER GRADE ISOCITRATE DEHYDROGENASE (IDH) MUTANT GLIOMAS METABOLICALLY MIMICKING GLIOBLASTOMA (GBM) EXPRESS HIGHER R:S 2-HYDROXYGLUTARATE RATIOS RELATIVE TO NON-GBM-MIMICKING IDH MUTANT GLIOMAS
Romina Nejad , Farshad Nassiri , Yasin Mamatjan , Hao-Wen Sim
Neuro-oncology 20
2018
Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma
Jeremy Lewin , Swati Garg , Beatrice Y. Lau , Brendan C. Dickson
International Journal of Cancer 142 ( 1) 57 -65
14
2018
Tissue 2-Hydroxyglutarate as a Biomarker for Isocitrate Dehydrogenase Mutations in Gliomas
Hao-Wen Sim , Romina Nejad , Wenjiang Zhang , Farshad Nassiri
Clinical Cancer Research 25 ( 11) 3366 -3373
5
2019
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer.
Di Maria Jiang , Hao-Wen Sim , Osvaldo Espin-Garcia , Bryan A. Chan
Oncology 99 ( 1) 49 -56
1
2021
QOLP-23. PHASE II RANDOMISED PLACEBO-CONTROLLED DOUBLE-BLIND STUDY OF ACETAZOLAMIDE VERSUS PLACEBO FOR CEREBRAL OEDEMA IN RECURRENT AND/OR PROGRESSIVE HIGH-GRADE GLIOMA REQUIRING TREATMENT WITH DEXAMETHASONE
Meera Agar , Anna Nowak , Elizabeth Hovey , Elizabeth Barnes
Neuro-oncology 22
2020
PARP inhibitors in glioma: a review of therapeutic opportunities
Hao-Wen Sim , Evanthia Galanis , Mustafa Khasraw
Cancers 14 ( 4) 1003
14
2022
CTIM-24. Nutmeg: a randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed elderly patients with glioblastoma
Hao-Wen Sim , Zarnie Lwin , Elizabeth Barnes , Kerrie McDonald
Neuro-Oncology 24 ( Suppl 7) vii65 -vii65
6
2022
Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma
Benjamin Y Kong , Hao-Wen Sim , Elizabeth H Barnes , Anna K Nowak
BMJ open 12 ( 9) e058107 -e058107
5
2022
What matters for people with brain cancer? Selecting clinical quality indicators for an Australian Brain Cancer Registry
Misa Matsuyama , Mythily Sachchithananthan , Robyn Leonard , Michael Besser
Neuro-Oncology Practice 9 ( 1) 68 -78
1
2022
RTID-05. THE MULTI-ARM GLIOBLASTOMA AUSTRALASIA (MAGMA) TRIAL
Benjamin Kong , Hao-Wen Sim , Eng-Siew Koh , Hui Gan
Neuro-Oncology 23 ( Supplement_6) vi193 -vi194
1
2021
NUTMEG: A RANDOMIZED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH GLIOBLASTOMA
Hao-Wen Sim , Zarnie Lwin , Elizabeth Barnes , Kerrie McDonald
NEURO-ONCOLOGY 24 65 -65
2022
Protocol: Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma
Benjamin Y Kong , Hao-Wen Sim , Elizabeth H Barnes , Anna K Nowak
BMJ Open 12 ( 9)
2022